• OUTLOOK ARENA
  • VIEWS ON NEWS
  • MARCH 26, 2001

Reckitt's stunner performance in FY01

Household care major, Reckitt Benckiser (earlier Reckitt & Colman India Ltd.), has recorded a 52% jump in profits for the year ended December 2000. The company's topline too witnessed an impressive double digit growth of 16%.

(Rs m) FY00 FY01 Change
Net Sales 5,040 5,849 16.1%
Other Income 61 85 38.9%
Interest 31 5 -84.5%
Profit after Tax/(Loss) 140 213 51.5%
Net profit margin (%) 2.8% 3.6%  
No. of Shares (eoy) 32.9 32.9  
Earnings per share 4.3 6.5  
Current P/e ratio   33  

Reckitt is the market leader in the household care segment. Its portfolio includes ultramarine blue, antiseptics, polishes, cosmetics, insect repellants and pharmaceuticals. The company has strong brands in each product segment it operates in. These include Robin (liquid bleach), Cherry Blossom (shoe polish), Harpic (toilet cleaner), Mortein (insect repellent), Lizol (disinfectant), Colin (glass cleaner) and Woolite (fine-fabric washing liquid).

The company's bottomline growth was fueled by a reduction of more than 80% in interest cost. Also a rise of 39% in other income led to higher profit growth.

This is indeed a remarkable performance by Reckitt, in light of the slowdown in topline growth of many FMCG companies. What is even more encouraging, is the company's efforts towards reducing its costs (through VRS and repaying its debts). All these efforts, especially the VRS is likely to add to the company's bottomline in the future.

During the current year, Reckitt is planning to launch mass market products from its parent's stable. The products are likely to be in the home care category, a business which Reckitt acquired internationally after its merger with Benckiser. The company expects the new products to contribute 20-22% of its total business in the current year. It also intends to penetrate rural markets aggressively by increasing distribution network. Apart from cost reduction exercise, these strategies of the company are further expected to help in maintaining its performance in the future.

At the current price of Rs 215, the stock trades at a P/E multiple of 33 times its FY01 earnings with a market cap to sales ratio of 1.2 times.

Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

Equitymaster Agora Research Private Limited (Research Analyst)
103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407